Defective regulation of the ubiquitin/proteasome system in the hypothalamus of obese male mice

Endocrinology

Volumn 155, Issue 8, 2014, Pages 2831-2844

  Ignacio Souza, Leticia M ^a   Bombassaro, Bruna ^a   Pascoal, Livia B ^a   Portovedo, Mariana A ^a   Razolli, Daniela S ^a   Coope, Andressa ^a   Victorio, Sheila C ^a   De Moura, Rodrigo F ^a   Nascimento, Lucas F ^a   Arruda, Ana P ^a   Anhe, Gabriel F ^a   Milanski, Marciane ^a   Velloso, Licio A ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALS; AUTOPHAGY; DIET, HIGH-FAT; DISEASE MODELS, ANIMAL; HUMANS; HYPOTHALAMUS; MALE; MICE; MICE, INBRED C3H; MICROGLIA; NEURONS; OBESITY; PHENOTYPE; PROTEASOME ENDOPEPTIDASE COMPLEX; TRANSCRIPTION FACTORS; UBIQUITIN; WEIGHT GAIN; WEIGHT LOSS;

EID: 84905020960     PISSN: 00137227     EISSN: 19457170     Source Type: Journal    
DOI: 10.1210/en.2014-1090     Document Type: Article

References (53)

1. Williams KW, Elmquist JK. From neuroanatomy to behavior: central integration of peripheral signals regulating feeding behavior. Nat Neurosci. 2012; 15:1350-1355.
2. Schwartz MW, Porte D Jr. Diabetes, obesity, and the brain. Science. 2005; 307:375-379.
3. Velloso LA, Schwartz MW. Altered hypothalamic function in diet-induced obesity. Int J Obes (Lond). 2011; 35:1455-1465.
4. De Souza CT, Araujo EP, Bordin S, et al. Consumption of a fat-rich diet activates a proinflammatory response and induces insulin resistance in the hypothalamus. Endocrinology. 2005; 146:4192-4199.
5. Milanski M, Degasperi G, Coope A, et al. Saturated fatty acids produce an inflammatory response predominantly through the activation of TLR4 signaling in hypothalamus: implications for the pathogenesis of obesity. J Neurosci. 2009; 29:359-370.
6. Zhang X, Zhang G, Zhang H, Karin M., Bai H, Cai D. Hypothalamic IKKβ/NF-κB and ER stress link overnutrition to energy imbalance and obesity. Cell. 2008; 135:61-73.
7. Moraes JC, Coope A, Morari J, et al. High-fat diet induces apoptosis of hypothalamic neurons. PLoS One. 2009; 4:e5045.
8. Ozcan L, Ergin AS, Myers MG Jr, et al. Endoplasmic reticulum stress plays a central role in development of leptin resistance. Cell Metab. 2009; 9:35-51.
9. van de Sande-Lee S, Pereira FR, Cintra DE, et al. Partial reversibility of hypothalamic dysfunction and changes in brain activity after body mass reduction in obese subjects. Diabetes. 2011; 60:1699-1704.
10. Thaler JP, Yi CX, Schur EA, et al. Obesity is associated with hypothalamic injury in rodents and humans. J Clin Invest. 2012; 122: 153-162.
11. Guo J, Jou W, Gavrilova O, Hall KD. Persistent diet-induced obesity in male C57BL/6 mice resulting from temporary obesigenic diets. PLoS One. 2009; 4:e5370.
12. Kraschnewski JL, Boan J, Esposito J, et al. Long-term weight loss maintenance in the United States. Int J Obes (Lond). 2010; 34:1644-1654.
13. Leibel RL. Molecular physiology of weight regulation in mice and humans. Int J Obes (Lond.) 2008; 32(SUPPL. 7):S98-S108.
14. Li J, Tang Y, Cai D. IKKβ/NF-κB disrupts adult hypothalamic neural stem cells to mediate a neurodegenerative mechanism of dietary obesity and pre-diabetes. Nat Cell Biol. 2012; 14:999-1012.
15. Welchman RL, Gordon C, Mayer RJ. Ubiquitin and ubiquitin-like proteins as multifunctional signals. Nat Rev Mol Cell Biol. 2005; 6:599-609.
16. Kirkin V, McEwan DG, Novak I, Dikic I. A role for ubiquitin in selective autophagy. Mol Cell. 2009; 34:259-269.
17. Vereecke L, Beyaert R, van Loo G. The ubiquitin-editing enzyme A20 (TNFAIP3) is a central regulator of immunopathology. Trends Immunol. 2009; 30:383-391.
18. Balch WE, Morimoto RI, Dillin A, Kelly JW. Adapting proteostasis for disease intervention. Science. 2008; 319:916-919.
19. Hotamisligil GS. Inflammation and metabolic disorders. Nature. 2006; 444:860-867.
20. Romanatto T, Roman EA, Arruda AP, et al. Deletion of tumor necrosis factor-α receptor 1 (TNFR1) protects against diet-induced obesity by means of increased thermogenesis. J Biol Chem. 2009; 284:36213-36222.
21. Tsukumo DM, Carvalho-Filho MA, Carvalheira JB, et al. Loss-of-function mutation in Toll-like receptor 4 prevents diet-induced obesity and insulin resistance. Diabetes. 2007; 56:1986-1998.
22. Johnson AK, Epstein AN. The cerebral ventricles as the avenue for the dipsogenic action of intracranial angiotensin. Brain Res. 1975; 86:399-418.
23. Kinote A, Faria JA, Roman EA, et al. Fructose-induced hypothalamic AMPK activation stimulates hepatic PEPCK and gluconeo-genesis due to increased corticosterone levels. Endocrinology. 2012; 153:3633-3645.
24. Leturque A, Ferre P, Burnol AF, Kande J, Maulard P., Girard J. Glucose utilization rates and insulin sensitivity in vivo in tissues of virgin and pregnant rats. Diabetes. 1986; 35:172-177.
25. Cardoso AR, Carvalho CR, Velloso LA, Brenelli S.L., Saad MJ, Carvalheira JB. Effect of thiopental, pentobarbital and diethyl ether on early steps of insulin action in liver and muscle of the intact rat. Life Sci. 2005; 76:2287-2297.
26. Prada PO, Zecchin HG, Gasparetti AL, et al. Western diet modulates insulin signaling, c-Jun N-terminal kinase activity, and insulin receptor substrate-1ser307 phosphorylation in a tissue-specific fashion. Endocrinology. 2005; 146:1576-1587.
27. Klionsky DJ, Abdalla FC, Abeliovich H, et al. Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy. 2012; 8:445-544.
28. Bence NF, Sampat RM, Kopito RR. Impairment of the ubiquitin-proteasome system by protein aggregation. Science. 2001; 292: 1552-1555.
29. Berke SJ, Paulson HL. Protein aggregation and the ubiquitin pro-teasome pathway: gaining the UPPer hand on neurodegeneration. Curr Opin Genet Dev. 2003; 13:253-261.
30. Rossmeisl M, Rim JS, Koza RA, Kozak LP. Variation in type 2 diabetes-related traits in mouse strains susceptible to diet-induced obesity. Diabetes. 2003; 52:1958-1966.
31. Bumaschny VF, Yamashita M, Casas-Cordero R, et al. Obesity-programmed mice are rescued by early genetic intervention. J Clin Invest. 2012; 122:4203-4212.
32. Komatsu M, Waguri S, Koike M, et al. Homeostatic levels of p62 control cytoplasmic inclusion body formation in autophagy-defi-cient mice. Cell. 2007; 131:1149-1163.
33. Gal J, Strom AL, Kilty R, Zhang F, Zhu H. p62 accumulates and enhances aggregate formation in model systems of familial amyotrophic lateral sclerosis. J Biol Chem. 2007; 282:11068-11077.
34. Susaki E, Kaneko-Oshikawa C, Miyata K, et al. Increased E4 activity in mice leads to ubiquitin-containing aggregates and degeneration of hypothalamic neurons resulting in obesity. J Biol Chem. 2010; 285: 15538-15547.
35. Meng Q, Cai D. Defective hypothalamic autophagy directs the central pathogenesis of obesity via the IκB kinase β (IKKβ)/NF-κB pathway. J Biol Chem. 2011; 286:32324-32332.
36. Coupe B, Ishii Y, Dietrich MO, Komatsu M, Horvath T.L., Bouret SG. Loss of autophagy in pro-opiomelanocortin neurons perturbs axongrowth and causes metabolic dysregulation. Cell Metab. 2012; 15:247-255.
37. Arruda AP, Milanski M, Coope A, et al. Low-grade hypothalamic inflammation leads to defective thermogenesis, insulin resistance, and impaired insulin secretion. Endocrinology. 2011; 152:1314-1326.
38. Bingol B, Sheng M. Deconstruction for reconstruction: the role of proteolysis in neural plasticity and disease. Neuron. 2011; 69:22-32.
39. Nath D, Shadan S. The ubiquitin system. Nature. 2009; 458:421.
40. Ciechanover A. Intracellular protein degradation: from a vague idea thru the lysosome and the ubiquitin-proteasome system and onto human diseases and drug targeting. Exp Biol Med (Maywood). 2006; 231:1197-1211.
41. Yi JJ, Ehlers MD. Emerging roles for ubiquitin and protein degradation in neuronal function. Pharmacol Rev. 2007; 59:14-39.
42. Almeida CG, Takahashi RH, Gouras GK. β-Amyloid accumulation impairs multivesicular body sorting by inhibiting the ubiquitin-proteasome system. J Neurosci. 2006; 26:4277-4288.
43. Bedford L, Hay D, Devoy A, et al. Depletion of 26S proteasomes in mouse brain neurons causes neurodegeneration and Lewy-like inclusions resembling human pale bodies. J Neurosci. 2008; 28:8189-8198.
44. van Wijk SJ, de Vries SJ, Kemmeren P, et al. A comprehensive framework of E2-RING E3 interactions of the human ubiquitin-proteasome system. Mol Syst Biol. 2009; 5:295.
45. Hobler SC, Tiao G, Fischer JE, Monaco J, Hasselgren PO. Sepsis-induced increase in muscle proteolysis is blocked by specific pro-teasome inhibitors. Am J Physiol. 1998; 274:R30-R37.
46. Diaz-Hernandez M, Martin-Aparicio E, Avila J, Hernandez F., Lucas JJ. Enhanced induction of the immunoproteasome by interferon y in neurons expressing mutant Huntingtin. Neurotox Res. 2004; 6: 463-468.
47. Murton AJ, Constantin D, Greenhaff PL. The involvement of the ubiquitin proteasome system in human skeletal muscle remodelling and atrophy. Biochim Biophys Acta. 2008; 1782:730-743.
48. Ryu KY, Garza JC, Lu XY, Barsh G.S., Kopito RR. Hypothalamic neurodegeneration and adult-onset obesity in mice lacking the Ubb polyubiquitin gene. Proc Natl Acad Sci USA. 2008; 105:4016-4021.
49. Qi L, Cho YA. Gene-environment interaction and obesity. Nutr Rev. 2008; 66:684-694.
50. Abete I, Astrup A, Martinez JA, Thorsdottir I, Zulet MA. Obesity and the metabolic syndrome: role of different dietary macronutrient distribution patterns and specific nutritional components on weight loss and maintenance. Nutr Rev. 2010; 68:214-231.
51. Bomfim TR, Forny-Germano L, Sathler LB, et al. An anti-diabetes agent protects the mouse brain from defective insulin signaling caused by Alzheimer's disease-associated Abeta oligomers. J Clin Invest. 2012; 122:1339-1353.
52. Xu WL, Atti AR, Gatz M, Pedersen NL, Johansson B, Fratiglioni L. Midlife overweight and obesity increase late-life dementia risk: a population-based twin study. Neurology. 2011; 76:1568-1574.
53. Chen H, Zhang SM, Schwarzschild MA, Hernan M.A., Willett WC, Ascherio A. Obesity and the risk of Parkinson's disease. Am J Epidemiol. 2004; 159:547-555.